Bacil Pharma informs about quarterly statement on investor complaints
19 Oct 2016
Bacil Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
Related Bacil Pharma Ltd. Links:
2.80
0.00 (0.00%)
Jul 06, 18:01
1 Year Price Chart
Peers
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 493.45 |
| Dr. Reddys Lab | 3905.80 |
| Lupin | 860.75 |
| Piramal Enterprises | 1449.20 |
| Cadila Healthcare | 356.25 |
| View more.. | |
Sensex vs Bacil Pharma
